Immune responses required for long lasting protection from SARS-CoV-2 has been revealed by a study in the journal mSphere, an open access journal of the American Society for…
The study team along with the collaboration from Faron Pharmaceuticals had developed an antibody - that is under clinical trials. The changes occurring in the defence systems of patients…